Eric Snoeck, Stephanos J. Hadziyannis, Claudio Puoti, Mark G. Swain, Thomas Berg, et al.. Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin..
Liver International, Wiley-Blackwell, 2008, 28 (1), pp.61-71.
⟨10.1111/j.1478-3231.2007.01603.x⟩.
⟨inserm-00324956⟩